511 related articles for article (PubMed ID: 2140831)
21. Comparison between spontaneous gonadotropin concentration profiles and gonadotropin response to low-dose gonadotropin-releasing hormone in prepubertal and early pubertal boys and patients with hypogonadotropic hypogonadism: assessment by using ultrasensitive, time-resolved immunofluorometric assay.
Goji K; Tanikaze S
Pediatr Res; 1992 May; 31(5):535-9. PubMed ID: 1603636
[TBL] [Abstract][Full Text] [Related]
22. Cortisol regulates secretion and pituitary content of the two gonadotropins differentially in female rats: effects of gonadotropin-releasing hormone antagonist.
Ringstrom SJ; Suter DE; Hostetler JP; Schwartz NB
Endocrinology; 1992 Jun; 130(6):3122-8. PubMed ID: 1597133
[TBL] [Abstract][Full Text] [Related]
23. Suppression of bioactive and immunoreactive follicle-stimulating hormone and luteinizing hormone levels by a potent gonadotropin-releasing hormone antagonist: pharmacodynamic studies.
Mortola JF; Sathanandan M; Pavlou S; Dahl KD; Hsueh AJ; Rivier J; Vale W; Yen SS
Fertil Steril; 1989 Jun; 51(6):957-63. PubMed ID: 2498133
[TBL] [Abstract][Full Text] [Related]
24. Active immunization of gilts against gonadotropin-releasing hormone: effects on secretion of gonadotropins, reproductive function, and responses to agonists of gonadotropin-releasing hormone.
Esbenshade KL; Britt JH
Biol Reprod; 1985 Oct; 33(3):569-77. PubMed ID: 2932169
[TBL] [Abstract][Full Text] [Related]
25. More basic isoforms of serum gonadotropins during gonadotropin-releasing hormone agonist therapy in pubertal children.
Wide L; Albertsson-Wikland K; Phillips DJ
J Clin Endocrinol Metab; 1996 Jan; 81(1):216-21. PubMed ID: 8550754
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the suppressive capacity of different depot gonadotropin-releasing hormone analogs in women.
Filicori M; Flamigni C; Cognigni G; Dellai P; Arnone R; Falbo A; Capelli M
J Clin Endocrinol Metab; 1993 Jul; 77(1):130-3. PubMed ID: 8325935
[TBL] [Abstract][Full Text] [Related]
27. Normal ranges for immunochemiluminometric gonadotropin assays.
Neely EK; Hintz RL; Wilson DM; Lee PA; Gautier T; Argente J; Stene M
J Pediatr; 1995 Jul; 127(1):40-6. PubMed ID: 7608809
[TBL] [Abstract][Full Text] [Related]
28. Gonadal regulation of gonadotropin subunit gene expression: evidence for regulation of follicle-stimulating hormone-beta messenger ribonucleic acid by nonsteroidal hormones in female rats.
Dalkin AC; Haisenleder DJ; Ortolano GA; Suhr A; Marshall JC
Endocrinology; 1990 Aug; 127(2):798-806. PubMed ID: 2115433
[TBL] [Abstract][Full Text] [Related]
29. Treatment of prostatic cancer with a gonadotropin-releasing hormone agonist analog: acute and long term effects on endocrine functions of testis tissue.
Huhtaniemi I; Nikula H; Rannikko S
J Clin Endocrinol Metab; 1985 Oct; 61(4):698-704. PubMed ID: 2993345
[TBL] [Abstract][Full Text] [Related]
30. Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men.
Pavlou SN; Wakefield G; Schlechter NL; Lindner J; Souza KH; Kamilaris TC; Konidaris S; Rivier JE; Vale WW; Toglia M
J Clin Endocrinol Metab; 1989 Feb; 68(2):446-54. PubMed ID: 2537334
[TBL] [Abstract][Full Text] [Related]
31. A preponderance of circulating basic isoforms is associated with decreased plasma half-life and biological to immunological ratio of gonadotropin-releasing hormone-releasable luteinizing hormone in obese men.
Castro-Fernández C; Olivares A; Söderlund D; López-Alvarenga JC; Zambrano E; Veldhuis JD; Ulloa-Aguirre A; Méndez JP
J Clin Endocrinol Metab; 2000 Dec; 85(12):4603-10. PubMed ID: 11134115
[TBL] [Abstract][Full Text] [Related]
32. [Effects of gonadotropin releasing hormone analogues on chemotherapy-induced ovarian function damage in rats].
Peng P; Yang DZ; Zheng CY; Mo YQ; He YM; Zhang QX
Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):546-50. PubMed ID: 17983495
[TBL] [Abstract][Full Text] [Related]
33. Serum bioactive and immunoreactive follicle-stimulating hormone levels and the response to clomiphene in healthy young and elderly men.
Tenover JS; Dahl KD; Hsueh AJ; Lim P; Matsumoto AM; Bremner WJ
J Clin Endocrinol Metab; 1987 Jun; 64(6):1103-8. PubMed ID: 3106393
[TBL] [Abstract][Full Text] [Related]
34. Gonadotropin-releasing hormone testing in premature thelarche.
Choubtum L; Mahachoklertwattana P; Sriphrapradang A; Preeyasombat C
J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S33-8. PubMed ID: 10730515
[TBL] [Abstract][Full Text] [Related]
35. Gonadotropin secretion in prepubertal normal and agonadal children evaluated by ultrasensitive time-resolved immunofluorometric assays.
Ropelato MG; Escobar ME; Gottlieb S; Bergadá C
Horm Res; 1997; 48(4):164-72. PubMed ID: 9378462
[TBL] [Abstract][Full Text] [Related]
36. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.
Matsumoto AM
J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626
[TBL] [Abstract][Full Text] [Related]
37. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
[TBL] [Abstract][Full Text] [Related]
38. The dependency of bioactive follicle-stimulating hormone secretion on gonadotropin-releasing hormone in hypogonadal and cycling women.
Kessel B; Dahl KD; Kazer RR; Liu CH; Rivier J; Vale W; Hsueh AJ; Yen SS
J Clin Endocrinol Metab; 1988 Feb; 66(2):361-6. PubMed ID: 3123512
[TBL] [Abstract][Full Text] [Related]
39. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ
J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
[TBL] [Abstract][Full Text] [Related]
40. Reduction of gonadotropin-releasing hormone pulse frequency is associated with subsequent selective follicle-stimulating hormone secretion in women with polycystic ovarian disease.
Christman GM; Randolph JF; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1991 Jun; 72(6):1278-85. PubMed ID: 1902845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
